Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis

• Autors principals: Qiyan Zheng (Autor), Yahui Wang (Autor), Huisheng Yang (Autor), Luying Sun (Autor), Xinwen Fu (Autor), Ruojun Wei (Autor), Yu Ning Liu (Autor), Wei Jing Liu (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2021-01-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Objective: Daprodustat is a novel oral agent in treating anemia of chronic kidney disease (CKD), and several clinical trials have been conducted to compare daprodustat with recombinant human erythropoietin (rhEPO) or placebo. Our systematic review aimed to investigate the efficacy and safety of dapr...